Cranial neural tube defect after trimethoprim exposure

Abstract

ObjectivesThe Neural Tube Defects Research Group of University of Malaya was approached to analyze a tablet named TELSE, which may have resulted in a baby born with central nervous system malformation at the University of Malaya Medical Centre. In this animal experimental study, we investigated the content of TELSE and exposure of its contents that resulted in failure of primary neurulation.ResultsLiquid Chromatography Tandem Mass spectrophotometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound. The TELSE tablet-treated females produced significant numbers of embryos with exencephaly (n = 8, 36.4%, *P < 0.0001), in all litters. The TELSE tablet-treated females subsequently given folic acid did not result in pregnancies despite there being evidence of possible resorption. Furthermore, after multiple rounds of mating which did not yield viable pregnancies, eventually, 2 embryos with exencephaly were harvested in a litter of 6 at 0.05% w/v pure trimethoprim once. The use of trimethoprim, a folic acid antagonist, peri-conceptionally increased the risk of exencephaly in the mouse.Electronic supplementary materialThe online version of this article (10.1186/s13104-018-3593-1) contains supplementary material, which is available to authorized users.

Open Neural Tube Defects: A Case Presentation of 30-year-old Secundigravida with Spina Bifida of the Fetus

“…In 70-90% of cases abnormalities of corpus callosum such as hypoplasia or aplasia of the rostrum are presented. In closed spina bifida, the neural tube defect is covered with skin, there is no loss of cerebrospinal fluid, and cranial anatomy is normal [1,13,29].…”

Single nucleotide polymorphisms of PCP pathway related genes participate in the occurrence and development of neural tube defect

“…NTDs are a type of multifactorial disease, the result of genetic and environmental factors (Abdullah et al, 2018). A large number of studies have shown that 20% of NTDs is caused by genetic factors and 80% by non-genetic factors, but up to now, no breakthrough has been made in the etiology and pathogenesis of NTDs (Wang, 2017).…”

Demography and management outcome of neural tube defects in a Nigerian tertiary health institution

“…The CNS develops from the neuroectoderm, in the third week of gestation, following its folding and subsequent formation of a tube-like structure (Neural tube). 1 The anterior (rostral) and posterior (caudal) end usually closes respectively by 21 and 28 days after conception, with the closure beginning in the middle and extending in cranial and caudal directions. 1 From the rostral part, the brain (forebrain, midbrain, and hindbrain) develops, while the caudal part forms the spinal cord.…”

“…1 The anterior (rostral) and posterior (caudal) end usually closes respectively by 21 and 28 days after conception, with the closure beginning in the middle and extending in cranial and caudal directions. 1 From the rostral part, the brain (forebrain, midbrain, and hindbrain) develops, while the caudal part forms the spinal cord. 2 NTD may involve the whole length in a condition called posterior rachischisis, may remain open in the region of the brain because of the nonclosure of the anterior neuropore, resulting in a condition called anencephaly or the region of the spine (Spina bifida).…”